Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Gains A Fraction. More details...
CBT 200 Books Second-In-A-Row 50 Point Gain. More...
CBT 200 Takes A 47 Point Tumble. More details...
CBT 200 Falls 15 Points. More details...
CBT 200 Climbs 55 Points. More details...
CBT 200 Climbs 9 Points. More details...
CBT 200 Adds On 13 Points. More details...
CBT 200 Nets 38 Point Loss. More details...
CBT 200 Rises 35 Points. More details...
CBT 200 Adds On 13 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
